{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T01:29:58Z","timestamp":1769304598266,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12325-019-01218-8","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T13:02:52Z","timestamp":1579698172000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease"],"prefix":"10.1007","volume":"37","author":[{"given":"Andrew N.","family":"Nicolaides","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"issue":"5","key":"1218_CR1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJMra055289","volume":"355","author":"JJ Bergan","year":"2006","unstructured":"Bergan JJ, Schmid-Schonbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med. 2006;355(5):488\u201398.","journal-title":"N Engl J Med"},{"issue":"3","key":"1218_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.avsg.2007.03.011","volume":"21","author":"J Bergan","year":"2007","unstructured":"Bergan J. Molecular mechanisms in chronic venous insufficiency. Ann Vasc Surg. 2007;21(3):260\u20136.","journal-title":"Ann Vasc Surg"},{"key":"1218_CR3","doi-asserted-by":"crossref","unstructured":"Mansilha A, Sousa J. Pathophysiological mechanisms of chronic venous disease and implications for venoactive drug therapy. Int J Mol Sci. 2018;19(6).","DOI":"10.3390\/ijms19061669"},{"issue":"2","key":"1218_CR4","first-page":"105","volume":"31","author":"E Rabe","year":"2012","unstructured":"Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31(2):105\u201315.","journal-title":"Int Angiol"},{"key":"1218_CR5","volume-title":"Chronic venous diseases of the leg","author":"W Laing","year":"1992","unstructured":"Laing W. Chronic venous diseases of the leg. London: Office of Health Economics; 1992."},{"issue":"2","key":"1218_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.23736\/S0392-9590.18.03975-5","volume":"37","author":"SK Kakkos","year":"2018","unstructured":"Kakkos SK, Nicolaides AN. Efficacy of micronized purified flavonoid fraction (Daflon\u00ae) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Int Angiol. 2018;37(2):143\u201354.","journal-title":"Int Angiol"},{"issue":"3","key":"1218_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.23736\/S0392-9590.18.03999-8","volume":"37","author":"A Nicolaides","year":"2018","unstructured":"Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I. Int Angiol. 2018;37(3):181\u2013254.","journal-title":"Int Angiol"},{"issue":"1","key":"1218_CR8","first-page":"3","volume":"22","author":"YT Tsoukanov","year":"2017","unstructured":"Tsoukanov YT, Tsoukanov AY. Great saphenous vein transitory reflux in patients with symptoms related to chronic venous disorders, but without visible signs (C0s), and its correction with MPFF treatment. Phlebolymphology. 2017;22(1):3\u201311.","journal-title":"Phlebolymphology"},{"issue":"2","key":"1218_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.23736\/S0392-9590.16.03708-1","volume":"36","author":"YT Tsukanov","year":"2017","unstructured":"Tsukanov YT, Nikolaichuk AI. Orthostatic-loading-induced transient venous refluxes (day orthostatic loading test), and remedial effect of micronized purified flavonoid fraction in patients with telangiectasia and reticular vein. Int Angiol. 2017;36(2):189\u201396.","journal-title":"Int Angiol"},{"issue":"7","key":"1218_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s12325-018-0731-z","volume":"35","author":"VY Bogachev","year":"2018","unstructured":"Bogachev VY, Boldin BV, Turkin PY. Administration of micronized purified flavonoid fraction during sclerotherapy of reticular veins and telangiectasias: results of the National, Multicenter, Observational Program VEIN ACT PROLONGED-C1. Adv Ther. 2018;35(7):1001\u20138.","journal-title":"Adv Ther"},{"issue":"4","key":"1218_CR11","first-page":"181","volume":"20","author":"VY Bogachev","year":"2013","unstructured":"Bogachev VY, Golovanova OV, Kuzhetsov AN, Shekoian AO, The DECISION Investigators. Can micronized purified flavonoid fraction* (MPFF) improve outcomes of lower extremity varicose vein endovenous treatment? First results from the DECISION study. Phlebolymphology. 2013;20(4):181\u20137.","journal-title":"Phlebolymphology"},{"issue":"4","key":"1218_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.23736\/S0392-9590.19.04216-0","volume":"38","author":"A Mansilha","year":"2019","unstructured":"Mansilha A, Sousa J. Benefits of venoactive drug therapy in surgical or endovenous treatment for varicose veins: a systematic review. Int Angiol 2019;38(4):291\u20138.","journal-title":"Int Angiol"},{"key":"1218_CR13","doi-asserted-by":"crossref","unstructured":"Taengsakul N, Saikaew T, Chaiaroon N, et al. Inflammatory responses in varicose veins surgery: conventional venous stripping and endovenous radiofrequency ablation (EV-RFA). J Vasc Endovascr Ther 2019;4(1):9.","DOI":"10.24966\/AVS-7397\/100021"},{"issue":"2","key":"1218_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jvsv.2018.09.017","volume":"7","author":"HF Ashpitel","year":"2019","unstructured":"Ashpitel HF, Dabbs EB, Salguero FJ, Nemchand JL, La Ragione RM, Whiteley MS. Histopathologic differences in the endovenous laser ablation between jacketed and radial fibers, in an ex vivo dominant extrafascial tributary of the great saphenous vein in an in vitro model, using histology and immunohistochemistry. J Vasc Surg Venous Lymphat Disord. 2019;7(2):234\u201345.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"8","key":"1218_CR15","first-page":"410-2","volume":"84","author":"L Veverkova","year":"2005","unstructured":"Veverkova L, Kalac J, Jedlicka V, Wechsler J. Analysis of surgical procedures on the vena saphena magna in the Czech Republic and an effect of Detralex during its stripping. Rozhl Chir. 2005;84(8):410-2 (4\u20136).","journal-title":"Rozhl Chir"},{"issue":"4","key":"1218_CR16","first-page":"193","volume":"13","author":"L Veverkov\u00e1","year":"2006","unstructured":"Veverkov\u00e1 L, Kala\u010d J, Jedli\u010dka V, Wechsler J. Analysis of the various procedures used in great saphenous vein surgery in the Czech Republic and benefit of Daflon 500\u00a0mg to postoperative symptoms. Phlebolymphology. 2006;13(4):193\u20139.","journal-title":"Phlebolymphology"},{"issue":"6","key":"1218_CR17","doi-asserted-by":"publisher","first-page":"83S","DOI":"10.1016\/j.jvs.2011.06.001","volume":"54","author":"TF O\u2019Donnell Jr","year":"2011","unstructured":"O\u2019Donnell TF Jr, Balk EM. The need for an Intersociety Consensus Guideline for venous ulcer. J Vasc Surg. 2011;54(6):83S\u201390S.","journal-title":"J Vasc Surg"},{"issue":"2 Suppl","key":"1218_CR18","first-page":"1S","volume":"60","author":"TF O\u2019Donnell Jr","year":"2014","unstructured":"O\u2019Donnell TF Jr, Passman MA. Clinical practice guidelines of the Society for Vascular Surgery (SVS) and the American Venous Forum (AVF)\u2014management of venous leg ulcers. Introduction. J Vasc Surg. 2014;60(2 Suppl):1S\u20132S.","journal-title":"J Vasc Surg"},{"issue":"1","key":"1218_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/000331979704800111","volume":"48","author":"CV Ruckley","year":"1997","unstructured":"Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology. 1997;48(1):67\u20139.","journal-title":"Angiology"},{"key":"1218_CR20","first-page":"CD001899","volume":"5","author":"EA Nelson","year":"2014","unstructured":"Nelson EA, Hillman A, Thomas K. Intermittent pneumatic compression for treating venous leg ulcers. Cochrane Database Syst Rev. 2014;5:CD001899.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1218_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ejvs.2005.04.017","volume":"30","author":"P Coleridge-Smith","year":"2005","unstructured":"Coleridge-Smith P, Lok C, Ramelet AA. Venous leg ulcer: a meta-analysis of adjunctive therapy with micronized purified flavonoid fraction. Eur J Vasc Endovasc Surg. 2005;30(2):198\u2013208.","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01218-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-019-01218-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01218-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T09:23:21Z","timestamp":1713173001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-019-01218-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":21,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-01218-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"26 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}